Pictet Asset Management
NVAX icon

Pictet Asset Management’s Novavax NVAX Stock Holding History

Pictet Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Sell
16,444
-4,898
-23% -$43.9K ﹤0.01% 2049
2026
Q1 		$174K Buy
21,342
+5,051
+31% +$45.8K ﹤0.01% 1964
2025
Q4 		$109K Hold
16,291
– – ﹤0.01% 2010
2025
Q3 		$141K Hold
16,291
– – ﹤0.01% 1943
2025
Q2 		$103K Hold
16,291
– – ﹤0.01% 1934
2025
Q1 		$104K Hold
16,291
– – ﹤0.01% 1923
2024
Q4 		$131K Hold
16,291
– – ﹤0.01% 1939
2024
Q3 		$206K Hold
16,291
– – ﹤0.01% 1799
2024
Q2 		$206K Buy
16,291
+5,969
+58% +$60.1K ﹤0.01% 1743
2024
Q1 		$49.3K Hold
10,322
– – ﹤0.01% 1941
2023
Q4 		$49.5K Hold
10,322
– – ﹤0.01% 1936
2023
Q3 		$74.7K Buy
+10,322
New +$82.5K ﹤0.01% 1872

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Pictet Asset Management's NVAX Position: Q2 2026 in Review

Pictet Asset Management reduced its Novavax (NVAX) stake by 23% in Q2 2026, selling an estimated $43.9K and leaving 16,444 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #2049.

Pictet Asset Management first reported a position in NVAX in Q3 2023 and has held it in 12 quarters since. The position peaked at $206K in Q2 2024. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Pictet Asset Management held 16,444 shares of Novavax worth $155K as of Q2 2026.
  • Pictet Asset Management sold 4,898 Novavax shares in Q2 2026, an estimated $43.9K.
  • Novavax made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #2049 holding.
  • Pictet Asset Management first reported a position in Novavax in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Novavax position peaked at $206K in Q2 2024.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.